Search
for
Sort by
Research 30 of 1000+
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- P042 A rare case of constrictive pericarditis with co-existing positive COVID-19: probable autoimmune or immunoglobulin related disease
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Factors Associated with Acute Telogen Effluvium and COVID-19 Infection
- A prospective cross-sectional study on post COVID-19 hair loss at a tertiary care hospital
- Telogen effluvium: Long term Covid-19 symptom
- Incidence and probable risk factors of post COVID syndrome among COVID-19 patients in urban population of North Kerala: a 6 months cohort study
- Male balding is a major risk factor for severe COVID-19
- A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- After Math of COVID Through Eyes of Tricoscopy
- Tratamento do Eflúvio Telógeno Pós-Covid 19
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- Clinical Diagnosis of COVID-19: a Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis).
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis).
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- Telogen effluvium in the new SARS‐CoV‐2 era
- Diffused alopecia followed by severe acute respiratory syndrome coronavirus-2 infection
- Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- Sudden Hairloss and COVID-19
- Autoimmunità e Covid-19: uno studio prospettico monocentrico di follow-up
- Characterization of Post-COVID-19 Clinical Manifestations Among Patients Visiting a Post-COVID-19 Clinic in a Tertiary Care Center: A Descriptive Study
- Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- COVID-19 infection leading to acute pustular dermatoses
- 067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases